• Acute and Chronic Kernicterus: MR Imaging Evolution of Globus Pallidus Signal Change during Childhood
• Advances to diminish global newborn kernicterus mortality
• An egg a day keeps kernicterus away
• Antenatal jaundice instruction and acute bilirubin encephalopathy in Nigeria
• Application of machine learning algorithms for accurate determination of bilirubin level on in vitro engineered tissue phantom images
• Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population
• Better assessment of neonatal jaundice at home (BEAT Jaundice @home): protocol for a prospective, multicentre diagnostic study
• Bilirubin Encephalopathy
• Bilirubin impacts microglial autophagy via the Akt-mTOR signaling pathway
• Bilirubin induces microglial NLRP3 inflammasome activation in vitro and in vivo
• Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models
• Bilirubin-induced neurotoxicity and visuocortical dysfunction
• Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia
• Case report: Crigler-Najjar syndrome type 1 in Croatia-more than a one in a million: a case series
• Cerebral Palsy
• Chemoprevention of bilirubin encephalopathy with a nanoceutical agent
• Childhood Health and Educational outcomes afteR perinatal Brain injury (CHERuB): protocol for a population-matched cohort study
• Childhood Neurologic Conditions: Movement Disorders
• Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
• Comparison of prognosis between hyperbilirubinemic infants with and without hypernatremia
• Comparison of severity and prognosis of jaundice due to Rh incompatibility and G6PD deficiency
• Conjugated Hyperbilirubinemia
• Conjugated Hyperbilirubinemia
• Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border
• Cord blood albumin as a predictor of neonatal jaundice
• Correction: Advances to diminish global newborn kernicterus mortality
• Crigler-Najjar Syndrome
• Crigler-Najjar Syndrome
• Crigler-Najjar type II in pregnancy: A case report
• Demystifying non-invasive approaches for screening jaundice in low resource settings: a review
• Determinants of neonatal jaundice in Ethiopia: a systematic review and meta-analysis
• Diagnostics Value of Quantitative Magnetic Resonance Imaging (MRI) in Neonatal Acute Bilirubin Encephalopathy
• Docosahexaenoic Acid Supplementation for Neonatal Hyperbilirubinemia: A Double-Blind, Randomized Clinical Trial
• Dynamic whole-transcriptome landscape of acute bilirubin encephalopathy in newborns
• Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn
• Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial
• Effects of Repetitive Transcranial Magnetic Stimulation on Pallidum GABAergic Neurons and Motor Function in Rat Models of Kernicterus
• Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review
• Etiology analysis for term newborns with severe hyperbilirubinemia in eastern Guangdong of China
• Evaluating the relationship between aEEG findings and two-year prognosis in neonates with severe hyperbilirubinemia
• Evidence Suggests a Decrease in the Incidence of Kernicterus in California
• Exchange Transfusion Trends and Risk Factors for Extreme Neonatal Hyperbilirubinemia over 10 Years in Shiraz, Iran
• Exchange Transfusions in Late Preterm and Term Neonates with Acute Bilirubin Encephalopathy
• Experiences with neonatal jaundice management in hospitals and the community: interviews with Australian health professionals
• Forgoing Exchange Transfusion in Neonatal Hyperbilirubinemia: A Single-Center Retrospective Cohort Study
• Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome
• Globus pallidus/putamen T₁WI signal intensity ratio in grading and predicting prognosis of neonatal acute bilirubin encephalopathy
• Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity
• Grand Rounds Hyperbilirubinemia following Phototherapy in Glucose-6-Phosphate Dehydrogenase-Deficient Neonates: Not Out of the Woods
• Hemolytic Disease of the Fetus and Newborn
• Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies
• Hemolytic Disease of the Newborn
• Hemolytic Diseases of the Newborn
• Hereditary TTP/Upshaw-Schulman syndrome: the ductus arteriosus controls newborn survival
• Hierarchical decision model for <em>in vitro</em> bilirubin content prediction from absorption spectrum of whole blood
• Impaired Bilirubin Conjugation
• Impaired Bilirubin Conjugation
• Implementation of neonatal phototherapy with the BiliCocoon Bag® device in the maternity ward and impact on mother-infant separation
• Inhibition of Microglial Activation Ameliorates Inflammation, Reduced Neurogenesis in the hippocampus, and Impaired Brain Function in a Rat Model of Bilirubin Encephalopathy
• Intermittent phototherapy versus continuous phototherapy for neonatal jaundice
• Interpretation of the 2022 American Academy of Pediatrics guidelines for the management of hyperbilirubinemia in newborn infants
• Kernicterus
• Kernicterus
• Kernicterus in neonates from ethnic minorities in the UK
• Kernicterus on the Spectrum
• Magnetic resonance spectroscopy and auditory brain-stem response audiometry as predictors of bilirubin-induced neurologic dysfunction in full-term jaundiced neonates
• Management challenges in the treatment of severe hyperbilirubinemia in low- and middle-income countries: Encouraging advancements, remaining gaps, and future opportunities
• Management of Neonatal Hyperbilirubinemia: Shedding Light on the American Academy of Pediatrics 2022 Clinical Practice Guideline Revision
• Managing the Historic Burden of Kernicterus Mortality in India
• Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia
• MGE-Like Neural Progenitor Cell Survival and Expression of Parvalbumin and Proenkephalin in a Jaundiced Rat Model of Kernicterus
• Molecular events in brain bilirubin toxicity revisited
• More than Meets the Eye: Exchange Transfusion in Neonates with Acute Bilirubin Encephalopathy
• Neonatal Hyperbilirubinemia
• Neonatal Hyperbilirubinemia: Evaluation and Treatment
• Network localization of pediatric lesion-induced dystonia
• POCT management of neonatal bilirubinemia - guidelines for an optimization of kernicterus monitoring
• POCT management of neonatal bilirubinemia – guidelines for an optimization of kernicterus monitoring
• Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort study
• Prevalence of alloantibodies associated with haemolytic disease of the fetus and newborn in pregnant women at the Ekiti State University Teaching Hospital, Ado-Ekiti, Southwest Nigeria
• Prospective cohort study of neurodevelopmental outcomes following extreme neonatal hyperbilirubinaemia in Australia
• Reducing the Time to Action on Bilirubin Results Overnight in a Newborn Nursery
• Risk Factors Predicting the Need for Phototherapy in Glucose 6 Phosphate Dehydrogenase-Deficient Infants in a Large Retrospective Cohort Study
• Second nationwide survey of bilirubin encephalopathy in preterm infants in Japan
• Severe Hyperbilirubinemia Secondary to Henna Application in a Neonate With G6PD Deficiency: A Case Report and Literature Review
• Supramolecular Organic Frameworks as Adsorbents for Efficient Removal of Excess Bilirubin in Hemoperfusion
• Susceptibility weighted imaging can be a sensitive sequence to detect brain damage in neonates with kernicterus: a case report
• Sustained lower bilirubin-binding affinity of albumin in extremely preterm infants
• Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
• The Etiologic Risk Factors for Cerebral Palsy at an Orthopedic Surgery Clinic in South Africa
• The Genetics of Glucose-6-Phosphate-Dehydrogenase (G6PD) and Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) Promoter Gene Polymorphism in Relation to Quantitative Biochemical G6PD Activity Measurement and Neonatal Hyperbilirubinemia
• The use of transcutaneous bilirubin nomograms for the prevention of bilirubin neurotoxicity in the neonates
• Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia
• Transcutaneous bilirubinometry for detecting jaundice in term or late preterm neonates
• Trends and Resource Use for Kernicterus Hospitalizations in the United States
• Trends in Neonatal Mortality at Princess Marie Louise Children's Hospital, Accra, and the Newborn Strategic Plan: Implications for Reducing Mortality in Hospital and the Community
• Unbound Bilirubin and Acute Bilirubin Encephalopathy in Infants Born Late Preterm and Term with Significant Hyperbilirubinemia
• Unconjugated Hyperbilirubinemia
• Unconjugated Hyperbilirubinemia
• Validation of a smartphone-based screening tool (Biliscan) for neonatal jaundice in a multi-ethnic neonatal population